Literature DB >> 34725743

Hypertrophic pachymeningitis in polyarteritis nodosa: a case-based review.

Shun Nomura1, Yasuhiro Shimojima2, Yasufumi Kondo1, Dai Kishida1, Yoshiki Sekijima1.   

Abstract

Hypertrophic pachymeningitis (HP) is a rare neurological disorder with focal or diffuse thickening of the dura mater, which usually causes headache, cranial neuropathies, seizures, and motor or sensory impairments. The development of HP is attributed to an immune-mediated mechanism, and some autoimmune diseases have been implicated in the development of HP. Herein, we describe the case of a 73-year-old woman with persistent headache ascribable to HP, which developed approximately 3 years after a diagnosis of polyarteritis nodosa (PAN). She was treated with high-dose corticosteroid and cyclophosphamide that resulted in immediate disappearance of headache and improved radiological findings of thickened dura mater. In addition, she was subsequently administered methotrexate, ultimately resulting in maintenance of remission and regular reduction of prednisolone. In our review of published English articles, only two cases of HP in patients with PAN have been reported to date, suggesting that HP is a rare complication in PAN. However, it should be recognized that HP may develop as a neurological involvement related to PAN.
© 2021. International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Headache; Hypertrophic pachymeningitis; Polyarteritis nodosa

Mesh:

Year:  2021        PMID: 34725743     DOI: 10.1007/s10067-021-05971-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  32 in total

1.  Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients.

Authors:  T Sakairi; N Sakurai; M Nakasatomi; H Ikeuchi; Y Kaneko; A Maeshima; Y Nojima; K Hiromura
Journal:  Scand J Rheumatol       Date:  2018-11-05       Impact factor: 3.641

2.  A nationwide survey of hypertrophic pachymeningitis in Japan.

Authors:  Tomomi Yonekawa; Hiroyuki Murai; Satoshi Utsuki; Takuya Matsushita; Katsuhisa Masaki; Noriko Isobe; Ryo Yamasaki; Mari Yoshida; Susumu Kusunoki; Kiyomi Sakata; Kiyotaka Fujii; Jun-ichi Kira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-11-22       Impact factor: 10.154

3.  Acute pachymeningitis mimicking subdural hematoma in a patient with polyarteritis nodosa.

Authors:  Jung-Soo Song; Myung-Kwan Lim; Bo-Hyoung Park; Won Park
Journal:  Rheumatol Int       Date:  2005-07-06       Impact factor: 2.631

4.  Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Yasuhiro Shimojima; Dai Kishida; Akiyo Hineno; Masahide Yazaki; Yoshiki Sekijima; Shu-Ichi Ikeda
Journal:  Int J Rheum Dis       Date:  2017-02-20       Impact factor: 2.454

Review 5.  Intravenous immunoglobulin-associated cranial pachymeningitis.

Authors:  I Marie; F Hervé; L Lahaxe; S Robaday; E Gerardin; H Levesque
Journal:  J Intern Med       Date:  2006-08       Impact factor: 8.989

6.  Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.

Authors:  Christian Pagnoux; Raphaèle Seror; Corneliu Henegar; Alfred Mahr; Pascal Cohen; Véronique Le Guern; Boris Bienvenu; Luc Mouthon; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2010-02

Review 7.  Diagnosis and classification of polyarteritis nodosa.

Authors:  José Hernández-Rodríguez; Marco A Alba; Sergio Prieto-González; Maria C Cid
Journal:  J Autoimmun       Date:  2014-01-28       Impact factor: 7.094

8.  Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and classification tree analysis.

Authors:  Aya Imafuku; Naoki Sawa; Masahiro Kawada; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Junichi Hoshino; Yoshihumi Ubara; Kenmei Takaichi
Journal:  Clin Rheumatol       Date:  2018-11-27       Impact factor: 2.980

9.  Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.

Authors:  Akiko Yokoseki; Etsuji Saji; Musashi Arakawa; Takayuki Kosaka; Mariko Hokari; Yasuko Toyoshima; Kouichirou Okamoto; Shigeki Takeda; Kazuhiro Sanpei; Hirotoshi Kikuchi; Shunsei Hirohata; Kouhei Akazawa; Akiyoshi Kakita; Hitoshi Takahashi; Masatoyo Nishizawa; Izumi Kawachi
Journal:  Brain       Date:  2013-11-22       Impact factor: 13.501

10.  Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.

Authors:  Junji Ikeda; Yasuhiro Shimojima; Yoko Usami; Ken-Ichi Ueno; Dai Kishida; Yoshiki Sekijima
Journal:  Clin Rheumatol       Date:  2020-02-08       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.